Skip to content
healthcare.dev

ADVAIR DISKUS

NDC 0173-0696, fluticasone propionate and salmeterol, powder, from GlaxoSmithKline LLC.

Product NDC
0173-0696
Status
Listed
Labeler
GlaxoSmithKline LLC
Dosage form
POWDER
Route
RESPIRATORY (INHALATION)
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021077
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0696 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SALMETEROL XINAFOATE50 ug/1
  • FLUTICASONE PROPIONATE250 ug/1

Pharmacologic classes

Adrenergic beta2-Agonists [MoA]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; beta2-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
0173-0696-00001730696001 INHALER in 1 CARTON (0173-0696-00) / 60 POWDER in 1 INHALER

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4eeb5f6a-593f-4a9e-9692-adefa2caf8fc
  • NADAC price for package 00173069600

    GET /v1/drugs/nadac/00173069600

Use it

Look up 0173-0696 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0696 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0173-0696. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.